Copeland Capital Management LLC lifted its position in CVS Health Corp (NYSE:CVS) by 13.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,747 shares of the pharmacy operator’s stock after acquiring an additional 8,017 shares during the quarter. Copeland Capital Management LLC’s holdings in CVS Health were worth $4,984,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Conning Inc. grew its stake in shares of CVS Health by 6.9% in the 4th quarter. Conning Inc. now owns 409,201 shares of the pharmacy operator’s stock worth $29,667,000 after acquiring an additional 26,510 shares in the last quarter. Lakeview Capital Partners LLC bought a new stake in shares of CVS Health in the 4th quarter worth $257,000. IFG Advisory LLC bought a new stake in shares of CVS Health in the 4th quarter worth $1,504,000. Twin Capital Management Inc. grew its stake in shares of CVS Health by 1.6% in the 4th quarter. Twin Capital Management Inc. now owns 112,240 shares of the pharmacy operator’s stock worth $8,137,000 after acquiring an additional 1,780 shares in the last quarter. Finally, Strategy Asset Managers LLC grew its stake in shares of CVS Health by 2.7% in the 4th quarter. Strategy Asset Managers LLC now owns 82,824 shares of the pharmacy operator’s stock worth $6,005,000 after acquiring an additional 2,165 shares in the last quarter. Hedge funds and other institutional investors own 83.11% of the company’s stock.
In other news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the sale, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Helena Foulkes sold 19,965 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total value of $1,418,313.60. Following the sale, the executive vice president now owns 65,072 shares in the company, valued at $4,622,714.88. The disclosure for this sale can be found here. Corporate insiders own 0.61% of the company’s stock.
Shares of CVS Health Corp (CVS) opened at $69.27 on Friday. CVS Health Corp has a 52-week low of $66.45 and a 52-week high of $84.00. The firm has a market capitalization of $70,276.63, a PE ratio of 11.70, a PEG ratio of 1.15 and a beta of 1.03. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59.
CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.88 by $0.04. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The firm had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. During the same period in the prior year, the business posted $1.71 earnings per share. The company’s revenue was up 5.3% on a year-over-year basis. sell-side analysts predict that CVS Health Corp will post 6.37 EPS for the current year.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.